The Anticancer Mechanisms of Scutellaria barbata against Lung Squamous Cell Carcinoma

被引:4
作者
Li, Feng [1 ]
Fu, Xianxian [2 ]
Liu, Lingli [1 ]
Wei, Xiaobin [2 ]
机构
[1] Hainan Med Univ, Hainan Affiliated Hosp, Hainan Gen Hosp, Dept Clin Lab, Haikou 570311, Hainan, Peoples R China
[2] Cent South Univ, Xiangya Sch Med, Dept Clin Lab, Haikou Affiliated Hosp, Haikou 570208, Hainan, Peoples R China
关键词
CANCER; APOPTOSIS; MIGRATION; PROMOTES; INVASION;
D O I
10.1155/2022/7529923
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Scutellaria barbata (S. barbata) is a Chinese traditional medicinal crop with anti-inflammatory as well as anticancer properties. To explore the anticancer mechanisms of functional monomers of S. barbata against lung squamous cell carcinoma (LUSC), a network pharmacology approach and molecular docking were utilized. Methods. The expression profile of genes encoding functional monomer components in S. barbata was obtained from the Traditional Chinese Medicine Systems Pharmacology platform (TCMSP) database. Expression data of LUSC-related genes were acquired from DisGeNET, GeneCards, OMIM, DrugBank, and TTD databases. The target genes of S. barbata that confer anticancer effects against LUSC were obtained by considering the intersecting genes between S. barbata target genes and LUSC-related genes. The potential regulatory pathways enriched in these intersected genes were identified using the KOBAS database, and Gene Ontology (GO) function enrichment analysis was performed using the online tool DAVID. The relationship network of S. barbata functional monomer components-action targets-disease-pathways was established using Cytoscape 3.8.2, and the protein-protein interaction network of those intersected genes was established using the STRING database. Finally, the hub genes were screened by using CytoNCA, a plug-in of Cytoscape, and hub gene expressions in LUSC were evaluated via the Gene Expression Profiling Interactive Analysis (GEPIA) database. AutoDockTools and PyMOL software were employed to verify the molecular docking on disease target proteins and drug functional molecules. Results. In S. barbata, 104 target genes and 20 hub genes encoding functional components against LUSC were screened out, six of which were significantly differentially expressed between LUSC samples and normal tissue samples in the GEPIA database. Here, GO analysis illustrated the involvement of these genes in the signal transduction and positive regulation of transcription from RNA polymerase II promoter and negative regulation of apoptosis, while KEGG pathway enrichment analysis demonstrated that these genes were mainly involved in several pathways, for instance, AGE-RAGE, PI3K-Akt, p53, and MAPK signaling pathway. There are four main functional components docking with six key target proteins, all of which have strong binding activity. Conclusions. We predicted the molecular mechanisms and signaling pathways of genes encoding functional components in S. barbata against LUSC. These discoveries offer novel understanding for further study, laying a scientific foundation for the production of synthetic monomer components of S. barbata.
引用
收藏
页数:12
相关论文
共 48 条
[1]   iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human [J].
Bergamaschi, D ;
Samuels, Y ;
O'Neil, NJ ;
Trigiante, G ;
Crook, T ;
Hsieh, JK ;
O'Connor, DJ ;
Zhong, S ;
Campargue, I ;
Tomlinson, ML ;
Kuwabara, PE ;
Lu, X .
NATURE GENETICS, 2003, 33 (02) :162-167
[2]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[3]   New TNM classification of non-small cell lung cancer [J].
Chassagnon, G. ;
Bennani, S. ;
Revel, M. -P. .
REVUE DE PNEUMOLOGIE CLINIQUE, 2017, 73 (01) :34-39
[4]   Wogonoside inhibits tumor growth and metastasis in endometrial cancer via ER stress-Hippo signaling axis [J].
Chen, Shaorong ;
Wu, Zhuna ;
Ke, Yumin ;
Shu, Pingping ;
Chen, Caihong ;
Lin, Ruying ;
Shi, Qirong .
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2019, 51 (11) :1096-1105
[5]   Squamous Cell Lung Cancer: From Tumor Genomics to Cancer Therapeutics [J].
Gandara, David R. ;
Hammerman, Peter S. ;
Sos, Martin L. ;
Lara, Primo N., Jr. ;
Hirsch, Fred R. .
CLINICAL CANCER RESEARCH, 2015, 21 (10) :2236-2243
[6]   Fibroblast-derived exosomal microRNA-369 potentiates migration and invasion of lung squamous cell carcinoma cells via NF1-mediated MAPK signaling pathway [J].
Guo, Liping ;
Li, Baoli ;
Yang, Jianjun ;
Shen, Juan ;
Ji, Jinshan ;
Miao, Meijing .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 46 (02) :595-608
[7]   TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer [J].
Hao, Xiang-lin ;
Han, Fei ;
Zhang, Ning ;
Chen, Hong-qiang ;
Jiang, Xiao ;
Yin, Li ;
Liu, Wen-bin ;
Wang, Dan-dan ;
Chen, Jian-ping ;
Cui, Zhi-hong ;
Ao, Lin ;
Cao, Jia ;
Liu, Jin-yi .
CELL DEATH AND DIFFERENTIATION, 2019, 26 (07) :1235-1250
[8]   Combining Machine Learning Systems and Multiple Docking Simulation Packages to Improve Docking Prediction Reliability for Network Pharmacology [J].
Hsin, Kun-Yi ;
Ghosh, Samik ;
Kitano, Hiroaki .
PLOS ONE, 2013, 8 (12)
[9]   Upregulation and activation of p53 by erastin-induced reactive oxygen species contribute to cytotoxic and cytostatic effects in A549 lung cancer cells [J].
Huang, Chaoli ;
Yang, Mengchang ;
Deng, Jia ;
Li, Peng ;
Su, Wenjie ;
Jiang, Rong .
ONCOLOGY REPORTS, 2018, 40 (04) :2363-2370
[10]   Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC) [J].
Ji, Meiju ;
Guan, Haixia ;
Gao, Cuixia ;
Shi, Bingyin ;
Hou, Peng .
BMC CANCER, 2011, 11